Skip to content
★ Sign in to follow
RA

Robert A. Hamm

Inhibitex IncBiogen Inc.
Total declarations
115
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (72 ops.)
€9.6M

Latest filing published 26 Apr 2010 for BIOGEN INC., €83k.

Insider track record

Disclosed buys
0
Disclosed sells
72
Signal history

No signal scores available.

Robert A. Hamm: trading record in brief

Robert A. Hamm discloses dealings in 2 companies, chiefly Biogen Inc. and Inhibitex Inc. Between 18 May 2006 and 23 April 2010, the trades on record add up to 115 filings.

Every open-market trade on record is a sale: 72 sales worth €9.6M. The rest of the record consists of 32 share grants and 11 option exercises. So far in 2010, the count stands at no purchases and 6 sales.

The record was last updated on 26 April 2010 with an open-market sale (€83k) in Biogen Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Robert A. Hamm

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations91 total
  • ▼
    Chief Operating OfficerExecutivesBiogen Inc.
    110,507 USD0SEC
    2,117 shares@ US$52.20Common StockSEC:0001127602-10-012025:0
  • ▼
    Chief Operating OfficerExecutivesBiogen Inc.
    111,604 USD0SEC
    2,138 shares@ US$52.20Common StockSEC:0001127602-10-012025:1
  • ▼
    Chief Operating OfficerExecutivesBiogen Inc.
    37,034 USD0SEC
    710 shares@ US$52.16Common StockSEC:0001127602-10-012025:2
  • ▼
    Chief Operating OfficerExecutivesBiogen Inc.
    36,690 USD0SEC
    703 shares@ US$52.19Common StockSEC:0001127602-10-012025:3
  • ◆
    Chief Operating OfficerExecutivesBiogen Inc.
    0SEC
    3,624 shares0Common StockSEC:0001127602-10-011242:0
  • ◆
    Chief Operating OfficerExecutivesBiogen Inc.
    29,048 USD0SEC
    505 shares@ US$57.52Common StockSEC:0001127602-10-010452:0
  • ◆
    Chief Operating OfficerExecutivesBiogen Inc.
    29,335 USD0SEC
    510 shares@ US$57.52Common StockSEC:0001127602-10-010452:1
  • ◆
    Chief Operating OfficerExecutivesBiogen Inc.
    0SEC
    9,306 shares0Common StockSEC:0001127602-10-006333:0
  • ▼
    Chief Operating OfficerExecutivesBiogen Inc.
    190,214 USD0SEC
    3,387 shares@ US$56.16Common StockSEC:0001127602-10-005573:1
  • ◆
    Chief Operating OfficerExecutivesBiogen Inc.
    89,054 USD0SEC
    1,613 shares@ US$55.21Common StockSEC:0001127602-10-005088:0
  • ◆
    Chief Operating OfficerExecutivesBiogen Inc.
    82,042 USD0SEC
    1,486 shares@ US$55.21Common StockSEC:0001127602-10-005088:1
  • ▼
    Chief Operating OfficerExecutivesBiogen Inc.
    99,724 USD0SEC
    2,330 shares@ US$42.80Common StockSEC:0001127602-09-021924:0
  • ▼
    Chief Operating OfficerExecutivesBiogen Inc.
    22,448 USD0SEC
    524 shares@ US$42.84Common StockSEC:0001127602-09-021924:1
  • ◆
    Chief Operating OfficerExecutivesBiogen Inc.
    15,841 USD0SEC
    376 shares@ US$42.13Common StockSEC:0001127602-09-021526:0
  • ◆
    Chief Operating OfficerExecutivesBiogen Inc.
    70,357 USD0SEC
    1,670 shares@ US$42.13Common StockSEC:0001127602-09-021526:1
  • ▼
    Chief Operating OfficerExecutivesBiogen Inc.
    109,152 USD0SEC
    2,194 shares@ US$49.75Common StockSEC:0001127602-09-014429:0
  • ▼
    Chief Operating OfficerExecutivesBiogen Inc.
    50,770 USD0SEC
    1,000 shares@ US$50.77Common StockSEC:0001127602-09-014429:1
  • ◆
    Chief Operating OfficerExecutivesBiogen Inc.
    0SEC
    3,660 shares0Common StockSEC:0001127602-09-008382:0
  • ◆
    EVP, Pharma. Oper. & Tech.ExecutivesBiogen Inc.
    0SEC
    9,400 shares0Common StockSEC:0001127602-09-005063:0
  • ▼
    EVP, Pharma. Oper. & Tech.ExecutivesBiogen Inc.
    173,671 USD0SEC
    3,412 shares@ US$50.90Common StockSEC:0001127602-09-004380:0
  • ◆
    EVP, Pharma. Oper. & Tech.ExecutivesBiogen Inc.
    83,545 USD0SEC
    1,588 shares@ US$52.61Common StockSEC:0001127602-09-003788:1
  • ▼
    EVP, Pharma. Oper. & Tech.ExecutivesBiogen Inc.
    186,289 USD0SEC
    3,670 shares@ US$50.76Common StockSEC:0001127602-09-003607:0
  • ◇
    EVP, Pharma. Oper. & Tech.ExecutivesBiogen Inc.
    0SEC
    5,466 shares0Common StockSEC:0001127602-09-003026:0
  • ◆
    EVP, Pharma. Oper. & Tech.ExecutivesBiogen Inc.
    94,254 USD0SEC
    1,796 shares@ US$52.48Common StockSEC:0001127602-09-003026:1
  • ▼
    EVP, Pharma. Oper. & Tech.ExecutivesBiogen Inc.
    94,849 USD0SEC
    2,130 shares@ US$44.53Common StockSEC:0001127602-08-008924:0

25 of 91 declarations